Viralytics

Developing oncolytic virotherapy treatments for a range of cancers such as Melanoma, bladder cancer.

placeSydney, New South Wales, Australia calendar_todayFounded 2006 groups6 employees language viralytics.com

Innovation

13 patent families (7 granted) — focus: Human necessities, Chemistry & metallurgy, Emerging technologies; filing pace dormant. Cited 713 times.

YearFilings
20124
20132
20144
20155
20164
20172
20181
20192
20202

Investor mix

2 investors on record.

Investor typeCountShare
Venture capital150%
Other / undisclosed150%
Coming soon